These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2575396)

  • 1. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 2. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
    Kharchenko EP; Klimenko AP
    Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lucky ones. How do some HIV-positive people avoid getting AIDS?
    Beardsley T
    Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
    Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
    Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS: an autoimmune pathologic model for the destruction of a subset of helper T lymphocytes.
    Shearer GM
    Mt Sinai J Med; 1986 Dec; 53(8):609-15. PubMed ID: 2949147
    [No Abstract]   [Full Text] [Related]  

  • 11. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
    Stricker RB; McHugh TM; Moody DJ; Morrow WJ; Stites DP; Shuman MA; Levy JA
    Nature; 1987 Jun 25-Jul 1; 327(6124):710-3. PubMed ID: 2955226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
    Zielinski C
    Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of cytotoxic T cell responses].
    Autran B
    Ann Rech Vet; 1992; 23(3):301-4. PubMed ID: 1384418
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper T-cell type 1 or type 2 function of xeno-MHC-restricted T-cell clones in a direct xenoantigen recognition.
    Iida Y; Iwata H; Mori Y; Takagi H; Nitta T; Kanetake K; Umeda Y; Hirose H
    Transpl Immunol; 2003; 11(2):169-73. PubMed ID: 12799200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
    Langlade-Demoyen P; Hoffenbach A
    Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
    [No Abstract]   [Full Text] [Related]  

  • 19. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.